Omer Stoller & Roy Rabinowitz
Co Founder & CEO, Co Founder & CTO
pharma & biotech
pharma & biotech

Kanso Diagnostics is developing a molecular diagnostics platform capable of at-home diagnostics with PCR test accuracy and antigen test simplicity & convenience. Kanso strives for a modern diagnostics experience suitable for today’s at-home medical revolution, accessible for all, and easy to use. Kanso’s novel platform is composed of a state-of-the-art lab on a chip, equipped with a CRISPR-based diagnostics system that can accurately detect multiple pathogens and genetic biomarkers from a single sample. It can reduce diagnosis time-to-results from days to minutes. Kanso’s proprietary technology enables an end-to-end solution for diagnosis of bacterial and viral infections anywhere, anytime and by anyone